Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Amgen
Pharma
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Biosimilars to Amgen’s lucrative bone drugs Prolia and Xgeva triumphed at the FDA, though ongoing patent litigation makes the launch timing uncertain.
Fraiser Kansteiner
Mar 6, 2024 9:52am
Drugmakers counter HHS' first offers in Medicare price talks
Mar 4, 2024 4:09pm
Amgen opens doors to cutting-edge biomanufacturing plant in Ohio
Feb 26, 2024 11:05am
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
Pharma-backed group wants patients to test their biomarkers
Feb 5, 2024 7:25am
Amgen's Prolia flagged by the FDA for risk of hypocalcemia
Jan 19, 2024 3:35pm